Barclays PLC Biotechnology

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CUE Cue Biopharma, Inc.	$24.8M	$4,000 0.0% of portfolio	6,029	Q3 2024 Reduced 67.05%
GBIO Generation Bio Co.	$353M	$4,000 0.0% of portfolio	11,483	Q2 2025 Reduced 81.22%
PEPG Pep Gen Inc.	$109M	$4,000 0.0% of portfolio	3,704	Q2 2025 Reduced 83.2%
APLT Applied Therapeutics Inc.	$28.8M	$3,000 0.0% of portfolio	11,103	Q2 2025 Reduced 91.4%
IGMS Igm Biosciences, Inc.	$36.8M	$3,000 0.0% of portfolio	2,800	Q2 2025 Reduced 85.4%
MRSN Mersana Therapeutics, Inc.	$757M	$3,000 0.0% of portfolio	9,767	Q2 2025 Reduced 91.98%
OCUP Ocuphire Pharma, Inc.	$20.2M	$2,000 0.0% of portfolio	1,900	Q1 2025 New
PASG Passage Bio, Inc.	$447M	$2,000 0.0% of portfolio	4,224	Q1 2025 Reduced 67.89%
STTK Shattuck Labs, Inc.	$98.8M	$2,000 0.0% of portfolio	2,114	Q2 2025 Reduced 95.85%
ADAP Adaptimmune Therapeutics PLC	$22.9M	$1,000 0.0% of portfolio	2,534	Q2 2025 Reduced 94.94%
EPIX Essa Pharma Inc.	$8.37M	$1,000 0.0% of portfolio	355	Q3 2024 New
HLVX Hille Vax, Inc.	$69.9M	$1,000 0.0% of portfolio	449	Q2 2025 Reduced 98.6%
IPHA Innate Pharma Sa	$154M	$1,000 0.0% of portfolio	307	Q3 2024 Reduced 25.49%
RPTX Repare Therapeutics Inc.	$73M	$1,000 0.0% of portfolio	530	Q2 2025 Reduced 12.4%
ATHA Athira Pharma, Inc.	$157M	$0 0.0% of portfolio	4	Q1 2025 Reduced 89.47%
CTMX Cytom X Therapeutics, Inc.	$210M	$0 0.0% of portfolio	2	Q1 2025 New
DYAI Dyadic International Inc	$33.8M	$0 0.0% of portfolio	72	Q2 2022 Reduced 99.05%
IMUX Immunic, Inc.	$26M	$0 0.0% of portfolio	123	Q2 2025 Reduced 99.78%
IMMP Immutep LTD	$156M	$0 0.0% of portfolio	16	Q4 2024 New
NBTX Nanobiotix S.A.	$705M	$0 0.0% of portfolio	4	Q4 2024 Reduced 96.36%
OVID Ovid Therapeutics Inc.	$90.1M	$0 0.0% of portfolio	71	Q2 2025 Reduced 99.89%
PROK Prokidney Corp Ord Shs Cl A(Cy	$153M	$0 0.0% of portfolio	1	Q2 2025 Reduced 100.0%
CRTX Cortexyme, Inc.	$70.5M	$0 0.0% of portfolio	23	Q1 2025 Reduced 77.0%
RLMD Relmada Therapeutics, Inc.	$53.8M	$0 0.0% of portfolio	1	Q2 2025 New
ENOB Enochian Biosciences Inc	$244M	$0 0.0% of portfolio	2	Q2 2025 Reduced 100.0%
SGMO Sangamo Therapeutics, Inc	$110M	$0 0.0% of portfolio	1	Q1 2025 Reduced 100.0%
VRCA Verrica Pharmaceuticals Inc.	$327M	$0 0.0% of portfolio	16	Q2 2025 Reduced 99.96%
XBIT X Biotech Inc.	$81.6M	$0 0.0% of portfolio	1	Q2 2025 Reduced 100.0%
ZNTL Zentalis Pharmaceuticals, Inc.	$84.9M	$0 0.0% of portfolio	1	Q2 2025 Reduced 100.0%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.